Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mukand Ltd. Regulatory Filings 2023

Apr 7, 2023

60966_rns_2023-04-07_9e9595a8-08de-486d-a7f7-441921b1de8f.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Mukand Ltd.

Regd. Office : Bajaj Bhawan, 3rd Floor Jamnalal Bajaj Marg 226 Nariman Point, Mumbai, India 400 021 Tel : 9122 61216666 Fax: 9122 2202 1174 www.mukand.com

Kalwe Works : Thane-Belapur Road Post office Kalwe, Thane, Maharashtra India 400 605 Tel: 9122 2172 7500 / 7700 Fax: 9122 2534 8179 CIN : L99999MH1937PLC002726

E-mail : [email protected]

April 07, 2023

Department of Corporate Services Listing Department Street, Mumbai — 400001 Bandra-Kurla Complex ISIN CODE : INE304A01026 Bandra (E), Mumbai — 400051

BSE Limited, National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Dalal Exchange Plaza, Plot no. C/1, G Block, ISIN CODE : INE304A01026 BSE Scrip Code : 500460 NSE Scrip Name : MUKAND LTD.

Dear Sirs

Sub: Intimation of Board Meeting for approval of Financial Results and recommendation of dividend Ref.: Regulation 29 of SEBI (LODR) Regulations, 2015

With reference to the above, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 16, 2023, inter-alia,

  • a) to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2023; and
  • b) to recommend dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2023.

Kindly take the above on your record.